Auf dieser Seite
VTRS Viatris Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$17,60
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,6952-Wochen-Tief
$18,4352-Wochen-Hoch
P/E
-4.2
EPS
$-3.00
Umsatz
$14.30B
Ihre Abzeichen
52W-Spanne
$10–$18
Analystenbewertung
BUY
Kursziel
$19
P/E
-4.2
ROE
-23.2%
Nettogewinnmarge
-24.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VTRS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$17.60
P/E
-4.2
EPS
$-3.00
Umsatz
$14.30B
ROE
-23.2%
Verschuldungsgrad (MRQ)
0.9
52W-Spanne
$10–$18
VTRS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 9. Oktober 2003 | 3-for-2 | Vorwärts |
| 28. Januar 2003 | 3-for-2 | Vorwärts |
| 16. August 1995 | 3-for-2 | Vorwärts |
| 3. August 1992 | 2-for-1 | Vorwärts |
Über Viatris Inc. - Common Stock Unternehmensübersicht von Wikipedia
Viatris ist ein US-amerikanisches Arzneimittelunternehmen mit Hauptsitz in Delaware in den Vereinigten Staaten.
## Geschichte
Viatris entstand im November 2020 durch die Fusion von Mylan mit Upjohn, einem Spin-off von Pfizer. Die Aktien werden seit dem 17. November 2020 an der Börse gehandelt.
Der Name Viatris ist ein Rückgriff auf die alte Firmierung der Pharmasparte von Degussa. Nach dem Verkauf der Pharmasparte durch Degussa im Jahre 2002 an einen Finanzinvestor wurde Viatris 2005 durch die schwedische MEDA aufgekauft. Die MEDA-Gruppe (mitsamt ihren Tochterfirmen, darunter Rottapharm Madaus) wurde wiederum 2016 von Mylan übernommen.
Im Jahr 2024 übernahm Cooper die OTC-Sparte von Viatris, darunter Marken wie Salviathymol, Allergodil und Transpulmin.
Viatris ist das einzige Unternehmen in Deutschland, das den Wirkstoff zur Bekämpfung einer Lebervergiftung durch Knollenblätterpilze herstellt.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealthcare
BranchePharmaceuticals
Mitarbeiter30.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$14.30B2018-12-31 → 2025-12-31
EPS$-3.002018-12-31 → 2025-12-31
Freier Cashflow$1.94B2025-12-31 → 2025-12-31
Nettogewinnmarge-24.6%2025-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VTRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -4.25-Jahres-Durchschnitt ≈36.5 | ≈36.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VTRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 34.8% | · | · | · | |
| Betriebsgewinnmarge (TTM) | -0.59% | · | 8.2% | Schwach | |
| EBITDA-Marge (TTM) | 18.4% | · | 5.2% | Schwach | |
| Vorgewinnmarge (TTM) | -4.5% | · | 8.1% | Schwach | |
| Net Profit Margin (Nettogewinnmarge) | -24.6% | · | 3.3% | Schwach | |
| ROA | -8.9% | · | 5.9% | Schwach | |
| ROE | -23.2% | · | 12.2% | Schwach | |
| ROIC | -8.8% | · | -0.21% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VTRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.9 | · | 1.2 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.6 | · | 1.6 | Im Einklang | |
| Quick Ratio | 0.6 | · | 0.9 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.8 | · | 1.2 | Geringe Verschuldung | |
| Interest Coverage (Zinsdeckungsgrad) | -5.7 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VTRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -3.0%5-Jahres-Durchschnitt ≈5.6% | ≈5.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -4.2%5-Jahres-Durchschnitt ≈-0.52% | ≈-0.52% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 3.7% | · | · | · | |
| EPS YoY (EPS VjV) | -97.1% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | -97.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VTRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.4 | · | 0.5 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 2.4 | · | 1.4 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 4.6 | · | 5.4 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$476.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Annualisierte Auszahlung≈$0.48
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Aug 21, 2026 | $0,12 | USD | ≈2.9% |
| Mai 22, 2026 | $0,12 | USD | ≈2.9% |
| Mär 9, 2026 | $0,12 | USD | ≈3.4% |
| Nov 24, 2025 | $0,12 | USD | ≈4.5% |
| Aug 22, 2025 | $0,12 | USD | ≈4.5% |
| Mai 23, 2025 | $0,12 | USD | ≈5.8% |
| Mär 10, 2025 | $0,12 | USD | ≈5.1% |
| Nov 22, 2024 | $0,12 | USD | ≈3.6% |
| Aug 23, 2024 | $0,12 | USD | ≈4.1% |
| Mai 23, 2024 | $0,12 | USD | ≈4.6% |
| Mär 8, 2024 | $0,12 | USD | ≈3.9% |
| Nov 22, 2023 | $0,12 | USD | ≈5.1% |
| Aug 23, 2023 | $0,12 | USD | ≈4.4% |
| Mai 23, 2023 | $0,12 | USD | ≈5.2% |
| Mär 8, 2023 | $0,12 | USD | ≈4.5% |
| Nov 22, 2022 | $0,12 | USD | ≈4.3% |
| Aug 23, 2022 | $0,12 | USD | ≈4.6% |
| Mai 23, 2022 | $0,12 | USD | ≈4.0% |
| Feb 23, 2022 | $0,12 | USD | ≈3.1% |
| Nov 22, 2021 | $0,11 | USD | ≈2.5% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.0%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $0.69 | $0.61 | 12.6% |
| 31. März 2026 | Mai 6, 2026 | $0.59 | $0.51 | 15.2% |
| 31. Dezember 2025 | $0.57 | $0.54 | 4.8% | |
| 30. September 2025 | $0.67 | $0.63 | 5.8% | |
| 30. Juni 2025 | $0.62 | $0.57 | 9.4% | |
| 31. März 2025 | $0.50 | $0.50 | 0.14% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | $11.43B | |
| Cost of Revenue | $9.29B | $9.12B | $8.99B | $9.77B | $12.31B | $8.15B | $7.60B | $7.43B | |
| Gross Profit | $5.01B | $5.62B | $6.44B | $6.50B | $5.58B | $3.80B | $3.90B | $4.00B | |
| R&D Expense | · | · | · | · | $751M | $555M | $640M | $704M | |
| SG&A Expense | $3.79B | $4.10B | $4.07B | $4.18B | $4.53B | $3.34B | $2.56B | $2.44B | |
| Operating Expenses | $7.68B | $5.61B | $5.67B | $4.88B | $5.61B | $4.01B | $3.18B | $3.10B | |
| Operating Income | $-2.66B | $10M | $766M | $1.61B | $-34M | $-211M | $716M | $906M | |
| Interest Expense | $471M | $550M | $573M | $592M | $636M | $498M | $517M | $542M | |
| Other Non-op | $-531M | $-83M | $10M | $1.79B | $6M | $-13M | $-44M | $-65M | |
| Pretax Income | $-3.67B | $-623M | $203M | $2.81B | $-664M | $-721M | $154M | $298M | |
| Income Tax | $-150M | $11M | $148M | $735M | $605M | $-51M | $138M | $-54M | |
| Net Income | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | $352M | |
| EPS (Basic) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.69 | |
| EPS (Diluted) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | $0.68 | |
| Shares (Basic) | · | · | 1,200,300,000 | 1,212,100,000 | 1,208,800,000 | 601,200,000 | 515,700,000 | 514,500,000 | |
| Shares (Diluted) | · | · | 1,206,900,000 | 1,217,400,000 | 1,208,800,000 | 601,200,000 | 516,500,000 | 516,500,000 | |
| EBITDA | $135M | · | · | · | · | · | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.32B | $735M | $992M | $1.26B | $701M | $844M | $476M | $388M | |
| Short-term Investments | · | · | · | · | · | $39M | $27M | · | |
| Receivables | $3.03B | $3.22B | $3.70B | $3.81B | $4.27B | $4.84B | $3.06B | · | |
| Inventory | $4.00B | $3.85B | $3.47B | $3.52B | $3.98B | $5.47B | $2.67B | · | |
| Prepaid Expense | $1.44B | $1.71B | $2.03B | $1.81B | $1.96B | $1.71B | $552M | · | |
| Other Current Assets | $136M | $387M | $271M | $328M | $1.47B | $1.24B | $286M | · | |
| Current Assets | $9.79B | $9.52B | $12.98B | $10.64B | $10.90B | $12.87B | $6.76B | · | |
| PP&E (Net) | $2.61B | $2.67B | $2.76B | $3.02B | $3.19B | $3.46B | $2.15B | · | |
| PP&E (Gross) | $5.13B | $4.87B | $4.77B | $5.08B | $5.59B | $5.72B | $4.12B | · | |
| Accum. Depreciation | $2.52B | $2.20B | $2.01B | $2.06B | $2.40B | $2.26B | $1.97B | · | |
| Goodwill | $6.75B | $9.13B | $9.87B | $10.43B | $12.11B | $12.35B | $9.59B | $9.75B | |
| Intangibles | $15.10B | $17.07B | $19.18B | $22.61B | $26.13B | $29.68B | $11.65B | · | |
| Other Non-current Assets | $1.87B | $2.36B | $2.21B | $2.40B | $1.17B | $1.05B | $405M | · | |
| Total Assets | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Short-term Debt | · | · | · | $0 | $1.49B | $1.10B | $0 | · | |
| Current Liabilities | $7.09B | $5.78B | $7.78B | $6.75B | $9.88B | $10.56B | $5.57B | · | |
| Capital Leases | $178M | $179M | $165M | $181M | $201M | $230M | $176M | · | |
| Deferred Tax | $892M | $1.11B | $1.74B | $2.43B | $2.81B | $3.12B | $1.63B | · | |
| Other Non-current Liabilities | $2.01B | $1.94B | $1.52B | $1.76B | $1.93B | $2.48B | $961M | · | |
| Total Liabilities | $22.48B | $22.87B | $27.22B | $28.95B | $34.35B | $38.60B | $19.37B | · | |
| Long-term Debt | $14.41B | $14.05B | $18.13B | $19.27B | $21.59B | $24.74B | $12.72B | · | |
| Total Debt | $14.41B | · | · | · | · | · | · | · | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | $12M | $6M | · | |
| Paid-in Capital | $18.80B | $18.92B | $18.81B | $18.65B | $18.54B | $18.44B | $8.64B | · | |
| Retained Earnings | $-388M | $3.42B | $4.64B | $5.18B | $3.69B | $5.36B | $6.03B | · | |
| Treasury Stock | $1.01B | $504M | $252M | $0 | $0 | $0 | $1000M | · | |
| AOCI | $-2.71B | $-3.21B | $-2.75B | $-2.76B | $-1.74B | $-858M | $-1.80B | · | |
| Stockholders' Equity | $14.71B | $18.64B | $20.47B | $21.07B | $20.49B | $22.95B | $11.88B | $12.17B | |
| Liabilities + Equity | $37.19B | $41.50B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | · | |
| Shares Outstanding | · | · | · | · | · | · | 100 | · |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.80B | $2.89B | $2.74B | $3.03B | $4.51B | $2.22B | $2.02B | $2.11B | |
| Stock-based Comp | $178M | $146M | $181M | $116M | $111M | $79M | $57M | $-3M | |
| Deferred Tax | $-476M | $-768M | $-387M | $-26M | $676M | $-213M | $-193M | $-264M | |
| Amort. of Intangibles | $2.35B | $2.35B | $2.32B | $2.50B | $2.70B | $1.61B | $1.58B | $1.61B | |
| Restructuring | · | · | · | · | $50M | $50M | $105M | · | |
| Other Non-cash | $3.33B | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.32B | $2.30B | $2.90B | $3.00B | $3.02B | $1.23B | $1.80B | $2.34B | |
| CapEx | $379M | $326M | $377M | $406M | $457M | $243M | $213M | $252M | |
| Investing Cash Flow | $-428M | $1.80B | $-864M | $1.47B | $-118M | $-301M | $-525M | $-1.21B | |
| Debt Issued | $0 | $0 | $300.0K | $1.88B | $1.71B | $983M | $7M | $2.58B | |
| Net Debt Issued | $-100.0K | · | · | · | · | · | · | · | |
| Stock Issued | $3M | $2M | $3M | $3M | $0 | $0 | · | · | |
| Stock Repurchased | $500M | $250M | $250M | $0 | $0 | $0 | $0 | $432M | |
| Net Stock Activity | $-498M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.29B | $-4.33B | $-2.30B | $-3.88B | $-3.01B | $-606M | $-1.17B | $-1.09B | |
| Net Change in Cash | $612M | $-258M | $-269M | $556M | $-144M | $359M | $102M | $19M | |
| Taxes Paid | $445M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.94B | · | · | · | · | · | · | · | |
| Levered FCF | $1.49B | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | · | · | · | · | · | · | · | |
| Operating Margin | -18.6% | · | · | · | · | · | · | · | |
| Net Margin | -24.6% | · | · | · | · | · | · | · | |
| Pretax Margin | -25.6% | · | · | · | · | · | · | · | |
| EBITDA Margin | 0.95% | · | · | · | · | · | · | · | |
| ROA | -8.9% | · | · | · | · | · | · | · | |
| ROE | -23.2% | · | · | · | · | · | · | · | |
| ROIC | -8.8% | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | · | · | · | · | · | · | · | |
| Quick Ratio | 0.6 | · | · | · | · | · | · | · | |
| Debt / Equity | 1.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.8 | · | · | · | · | · | · | · | |
| Interest Coverage | -5.7 | · | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | · | · | · | · | · | · | |
| Inventory Turnover | 2.4 | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $0.00 | · | |
| Dividend Paid / Share | $0.48 | $0.48 | $0.48 | $0.48 | $0.33 | · | · | · | |
| EPS (TTM) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.03 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% | · | · | · | |
| Revenue CAGR 3Y | -4.2% | -6.2% | 8.9% | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.7% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -97.1% | · | · | · | · | · | |
| Net Income YoY | · | · | -97.4% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.50B | · | |
| Net Income TTM | $-3.51B | $-634M | $55M | $2.08B | $-1.27B | $-670M | $17M | · | |
| Market Cap | · | · | · | · | · | · | $2.0K | · | |
| P/E | -4.2 | -23.5 | 216.6 | 6.5 | -12.9 | -16.9 | 670.0 | · | |
| P/S | · | · | · | · | · | · | 0.0 | · | |
| Earnings Yield | -24.1% | -4.3% | 0.46% | 15.4% | -7.8% | -5.9% | 0.15% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.76B | $3.52B | $3.70B | $3.76B | $3.58B | $3.25B | $3.53B | $3.75B | $3.80B | $3.66B | $3.84B | $3.94B | $3.92B | $3.73B | $3.88B | $4.08B | |
| Cost of Revenue | $2.30B | $2.36B | $2.56B | $2.39B | $2.25B | $2.09B | $2.31B | $2.29B | $2.35B | $2.16B | $2.24B | $2.25B | $2.31B | $2.19B | $2.60B | $2.33B | |
| Gross Profit | $1.46B | $1.16B | $1.15B | $1.37B | $1.33B | $1.16B | $1.22B | $1.46B | $1.45B | $1.50B | $1.60B | $1.69B | $1.61B | $1.54B | $1.27B | $1.75B | |
| R&D Expense | $248M | $249M | · | $250M | $219M | $222M | · | $198M | $204M | $200M | · | $211M | $208M | $183M | · | $175M | |
| SG&A Expense | $1.13B | $929M | $1.03B | $887M | $929M | $948M | $1.05B | $1.00B | $1.04B | $1.02B | $1.03B | $1.05B | $1.03B | $959M | $1.27B | $1.02B | |
| Operating Expenses | $1.45B | $1.24B | $1.34B | $1.19B | $1.10B | $4.04B | $1.39B | $1.23B | $1.69B | $1.30B | $2.05B | $1.24B | $1.24B | $1.14B | $1.48B | $1.19B | |
| Operating Income | $6M | $-80M | $-193M | $179M | $233M | $-2.88B | $-180M | $226M | $-240M | $204M | $-454M | $452M | $369M | $400M | $-201M | $560M | |
| Interest Expense | $121M | $120M | $120M | $120M | $117M | $116M | $120M | $146M | $146M | $138M | $141M | $142M | $144M | $147M | $147M | $153M | |
| Other Non-op | $50M | $-48M | $-31M | $-67M | $-334M | $-99M | $-226M | $10M | $-6M | $139M | $-260M | $92M | $108M | $70M | $1.82B | $21M | |
| Pretax Income | $-64M | $-247M | $-343M | $-8M | $-217M | $-3.10B | $-526M | $90M | $-392M | $205M | $-855M | $402M | $333M | $323M | $1.47B | $428M | |
| Income Tax | $55M | $-424M | $-3M | $120M | $-212M | $-55M | $-10M | $-4M | $-65M | $91M | $-89M | $71M | $69M | $98M | $458M | $73M | |
| EPS (Basic) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.44 | $0.08 | $-0.27 | $0.10 | $-0.64 | $0.28 | $0.22 | $0.19 | $0.83 | $0.29 | |
| EPS (Diluted) | $-0.10 | $0.15 | $-0.34 | $-0.11 | $0.00 | $-2.55 | $-0.43 | $0.08 | $-0.27 | $0.09 | $-0.63 | $0.27 | $0.22 | $0.19 | $0.83 | $0.29 | |
| Shares (Basic) | 1,163,300,000 | 1,155,400,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,193,500,000 | 1,191,100,000 | 1,195,200,000 | · | 1,199,500,000 | 1,199,000,000 | 1,202,500,000 | · | 1,212,500,000 | |
| Shares (Diluted) | 1,163,300,000 | 1,175,300,000 | · | 1,164,600,000 | 1,173,000,000 | 1,192,400,000 | · | 1,200,400,000 | 1,191,100,000 | 1,209,500,000 | · | 1,207,600,000 | 1,203,500,000 | 1,205,600,000 | · | 1,218,100,000 | |
| EBITDA | $6M | $596M | · | $179M | $233M | $-2.22B | · | $226M | $-240M | $895M | · | $452M | $369M | $1.13B | · | $560M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $886M | $1.80B | $1.32B | $975M | $566M | $755M | $735M | $1.88B | $917M | $1.01B | $992M | $1.31B | $629M | $507M | $1.26B | $647M | |
| Receivables | $3.13B | $3.08B | $3.03B | $3.37B | $3.26B | $3.13B | $3.22B | $3.72B | $3.57B | $3.63B | · | $3.74B | $3.61B | $3.50B | · | $3.33B | |
| Inventory | $3.93B | $3.93B | $4.00B | $4.11B | $4.26B | $4.10B | $3.85B | $4.08B | $3.94B | $3.82B | · | $3.67B | $3.64B | $3.66B | · | $3.38B | |
| Prepaid Expense | $2.11B | $2.11B | $1.44B | $1.49B | $1.69B | $1.65B | $1.71B | $1.63B | $1.76B | $1.93B | · | $1.78B | $1.73B | $1.76B | · | $1.70B | |
| Other Current Assets | $140M | $98M | $136M | $251M | $259M | $355M | $387M | $335M | $270M | $250M | · | $1.20B | $1.18B | $1.35B | · | $1.13B | |
| Current Assets | $10.06B | $10.92B | $9.79B | $9.95B | $9.77B | $9.62B | $9.52B | $11.31B | $11.79B | $12.92B | · | $10.93B | $9.78B | $9.63B | · | $10.49B | |
| PP&E (Net) | $2.44B | $2.53B | $2.61B | $2.63B | $2.64B | $2.64B | $2.67B | $2.68B | $2.66B | $2.71B | · | $2.93B | $2.98B | $3.01B | · | $3.04B | |
| PP&E (Gross) | $5.11B | $5.11B | $5.13B | $5.11B | $5.07B | $4.94B | $4.87B | $4.88B | $4.71B | $4.71B | · | $5.04B | $5.05B | $5.15B | · | $5.02B | |
| Accum. Depreciation | $2.67B | $2.58B | $2.52B | $2.48B | $2.42B | $2.30B | $2.20B | $2.21B | $2.05B | $2.00B | · | $2.11B | $2.06B | $2.14B | · | $1.98B | |
| Goodwill | $6.65B | $6.69B | $6.75B | $6.73B | $6.75B | $6.46B | $9.13B | $9.56B | $9.33B | $9.69B | $9.87B | $10.28B | $10.53B | $10.57B | $10.43B | $10.05B | |
| Intangibles | $13.68B | $14.48B | $15.10B | $15.72B | $16.32B | $16.66B | $17.07B | $17.98B | $18.42B | $19.13B | · | $21.28B | $22.08B | $22.70B | · | $23.01B | |
| Other Non-current Assets | $1.06B | $1.11B | $1.87B | $1.89B | $2.00B | $2.27B | $2.36B | $2.47B | $2.45B | $2.23B | · | $2.40B | $2.35B | $2.42B | · | $964M | |
| Total Assets | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $23M | $205M | · | $500M | |
| Current Liabilities | $6.35B | $6.81B | $7.09B | $7.36B | $7.13B | $5.72B | $5.78B | $7.51B | $7.71B | $7.76B | · | $6.83B | $6.52B | $6.11B | · | $6.52B | |
| Capital Leases | $160M | $167M | $178M | $171M | $182M | $177M | $179M | $188M | $192M | $156M | · | $160M | $167M | $173M | · | $179M | |
| Deferred Tax | $803M | $871M | $892M | $1.03B | $1.08B | $1.08B | $1.11B | $1.28B | $1.57B | $1.67B | · | $2.32B | $2.41B | $2.46B | · | $2.49B | |
| Other Non-current Liabilities | $2.02B | $2.08B | $2.01B | $1.82B | $1.84B | $1.84B | $1.94B | $1.87B | $1.80B | $1.83B | · | $1.65B | $1.67B | $1.72B | · | $1.75B | |
| Total Liabilities | $20.78B | $22.18B | $22.48B | $22.70B | $22.84B | $22.82B | $22.87B | $24.96B | $25.81B | $27.33B | · | $27.88B | $27.85B | $28.36B | · | $29.48B | |
| Long-term Debt | $13.35B | $14.34B | $14.41B | $14.44B | $14.47B | $14.19B | $14.05B | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.58B | $18.58B | · | $19.49B | |
| Total Debt | $13.35B | $14.34B | · | $14.44B | $14.47B | $14.19B | · | $15.75B | $17.10B | $17.97B | · | $18.38B | $18.60B | $18.78B | · | $19.99B | |
| Common Stock | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Paid-in Capital | $18.56B | $18.66B | $18.80B | $18.89B | $19.00B | $18.96B | $18.92B | $18.89B | $18.85B | $18.84B | · | $18.76B | $18.72B | $18.68B | · | $18.62B | |
| Retained Earnings | $-331M | $-212M | $-388M | $-48M | $80M | $228M | $3.42B | $4.08B | $4.13B | $4.61B | · | $5.55B | $5.37B | $5.25B | · | $4.31B | |
| Treasury Stock | $1.16B | $1.01B | $1.01B | $924M | $856M | $680M | $504M | $504M | $504M | $504M | · | $252M | $252M | $252M | · | · | |
| AOCI | $-2.82B | $-2.80B | $-2.71B | $-2.71B | $-2.66B | $-2.87B | · | $-2.69B | $-2.98B | $-2.94B | · | $-3.21B | $-3.01B | $-2.76B | · | $-3.76B | |
| Stockholders' Equity | $14.26B | $14.66B | $14.71B | $15.22B | $15.57B | $15.65B | $18.64B | $19.79B | $19.52B | $20.01B | $20.47B | $20.87B | $20.84B | $20.93B | $21.07B | $19.18B | |
| Liabilities + Equity | $35.04B | $36.83B | $37.19B | $37.92B | $38.41B | $38.47B | $41.50B | $44.75B | $45.33B | $47.34B | · | $48.74B | $48.70B | $49.29B | · | $48.66B |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $672M | $676M | $767M | $688M | $678M | $665M | $746M | $670M | $786M | $691M | $644M | $679M | $687M | $730M | $870M | $700M | |
| Stock-based Comp | $39M | $48M | $49M | $36M | $37M | $55M | $32M | $32M | $35M | $47M | $56M | $43M | $39M | $43M | $30M | $29M | |
| Deferred Tax | $-124M | $-70M | $-248M | $-137M | $-48M | $-44M | $-249M | $-312M | $-154M | $-52M | $-207M | $-85M | $-68M | $-27M | $154M | $-22M | |
| Amort. of Intangibles | $572M | $585M | $602M | $593M | $583M | $571M | $579M | $575M | $597M | $601M | $539M | $584M | $591M | $603M | $606M | $616M | |
| Restructuring | $27M | $78M | · | · | · | · | · | · | · | · | · | $15M | $74M | $10M | · | $15M | |
| Operating Cash Flow | $382M | $388M | $816M | $745M | $220M | $536M | $483M | $826M | $379M | $615M | $568M | $845M | $525M | $971M | $189M | $869M | |
| CapEx | $53M | $40M | $196M | $87M | $53M | $43M | $140M | $77M | $59M | $50M | $166M | $96M | $68M | $48M | $154M | $104M | |
| Investing Cash Flow | $-52M | $277M | $-211M | $-99M | $-52M | $-65M | $-169M | $1.75B | $376M | $-154M | $27M | $-65M | $-87M | $-750M | $1.74B | $-115M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $300.0K | $0 | $0 | $0 | $100.0K | $1.08B | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-750M | · | · | |
| Stock Issued | $700.0K | $500.0K | $600.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $700.0K | $600.0K | $600.0K | $800.0K | $800.0K | $900.0K | $800.0K | $2M | |
| Stock Repurchased | $150M | $0 | $82M | $68M | $175M | $175M | $0 | $0 | $0 | $250M | $0 | $0 | $0 | $250M | $0 | $0 | |
| Net Stock Activity | · | $500.0K | · | $-68M | $-175M | $-175M | · | · | · | $-249M | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-1.24B | $-204M | $-236M | $-228M | $-362M | $-467M | $-1.42B | $-1.64B | $-848M | $-426M | $-926M | $-98M | $-304M | $-975M | $-1.33B | $-759M | |
| Net Change in Cash | $-916M | $458M | $344M | $436M | $-188M | $20M | $-1.14B | $962M | $-97M | $22M | $-318M | $680M | $121M | $-752M | $612M | $-19M | |
| Free Cash Flow | · | $348M | · | · | · | $493M | · | · | · | $565M | · | · | · | $923M | · | · | |
| Levered FCF | · | $434M | · | · | · | $379M | · | · | · | $488M | · | · | · | $821M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.8% | 32.9% | · | 36.5% | 37.2% | 35.7% | · | 38.9% | 38.1% | 41.0% | · | 42.9% | 41.0% | 41.4% | · | 42.9% | |
| Operating Margin | 0.17% | -2.3% | · | 4.8% | 6.5% | -88.6% | · | 6.0% | -6.3% | 5.6% | · | 11.5% | 9.4% | 10.7% | · | 13.7% | |
| Pretax Margin | -1.7% | -7.0% | · | -0.21% | -6.1% | -95.2% | · | 2.4% | -10.3% | 5.6% | · | 10.2% | 8.5% | 8.6% | · | 10.5% | |
| EBITDA Margin | 0.17% | 17.0% | · | 4.8% | 6.5% | -68.1% | · | 6.0% | -6.3% | 24.4% | · | 11.5% | 9.4% | 30.3% | · | 13.7% | |
| ROIC | 0.04% | 0.20% | · | 9.8% | 0.02% | -9.5% | · | 0.67% | -0.55% | 0.30% | · | 0.95% | 0.74% | 0.70% | · | 1.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.6 | · | 1.4 | 1.4 | 1.7 | · | 1.5 | 1.5 | 1.7 | · | 1.6 | 1.5 | 1.6 | · | 1.6 | |
| Quick Ratio | 0.6 | 0.7 | · | 0.6 | 0.5 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | |
| Debt / Equity | 0.9 | 1.0 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| LT Debt / Equity | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 0.7 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Interest Coverage | 0.1 | -0.7 | · | 1.5 | 2.0 | -25.0 | · | 1.6 | -1.6 | 1.5 | · | 3.2 | 2.6 | 2.7 | · | 3.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 1.1 | 1.0 | · | 1.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.23 | $2.99 | · | $3.23 | $3.05 | $2.73 | · | $3.12 | $3.19 | $3.03 | · | · | · | $3.09 | · | $3.35 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.45 | · | · | · | $0.51 | · | · | · | $0.81 | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.12 | |
| Dividend Paid / Share | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | |
| EPS (TTM) | $-0.40 | $-0.30 | · | $-3.09 | $-2.90 | $-3.17 | · | $-0.73 | $-0.54 | $-0.05 | · | $1.51 | $1.53 | $1.57 | · | $0.66 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.74B | $14.56B | · | $14.12B | $14.12B | $14.33B | · | $15.05B | $15.24B | $15.36B | · | $15.47B | $15.60B | $15.80B | · | $16.73B | |
| Net Income TTM | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | $-670M | $-670M | · | $-670M | |
| P/E | -39.7 | -45.0 | · | -3.2 | -3.1 | -2.7 | · | -15.9 | -19.7 | -238.8 | · | 6.5 | 6.5 | 6.1 | · | 12.9 | |
| Earnings Yield | -2.5% | -2.2% | · | -31.2% | -32.5% | -36.4% | · | -6.3% | -5.1% | -0.42% | · | 15.3% | 15.3% | 16.3% | · | 7.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $14.30B | $14.74B | $15.43B | $16.26B | $17.89B |
| Bruttogewinnmarge % | 35.1% | · | · | · | · |
| Betriebsgewinnmarge % | -18.6% | · | · | · | · |
| Nettoergebnis | $-3.51B | $-634M | $55M | $2.08B | $-1.27B |
| Verwässerte EPS | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.0 | · | · | · | · |
| Liquiditätsgrad | 1.4 | · | · | · | · |
| Quick Ratio | 0.6 | · | · | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $1.94B | · | · | · | · |
Institutionelle Eigentümer (13F) 1.118 Einreicher · $17.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
1.118
Gehaltener Wert
$17.2B
Neue Positionen
109
Geschlossene Positionen
87
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 109 (-47 vs. Vorquartal) | 87 (-2 vs. Vorquartal) | 373 (+25 vs. Vorquartal) | 325 (+14 vs. Vorquartal) | +90.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.720.339.307 | 138.179.864 | 10,03% | Aktien |
| FMR LLC | $1.534.994.190 | 96.662.102 | 8,95% | Aktien |
| BlackRock, Inc. | $1.365.989.163 | 86.019.468 | 7,96% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.207.625.391 | 76.046.939 | 7,04% | Aktien |
| Davis Selected Advisers | $1.194.789.797 | 75.232.254 | 6,96% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $861.999.430 | 54.282.080 | 5,02% | Aktien |
| STATE STREET CORP | $842.743.041 | 53.069.461 | 4,91% | Aktien |
| Rubric Capital Management LP | $542.599.639 | 34.168.743 | 3,16% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $520.097.655 | 32.807.906 | 3,03% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $475.964.429 | 29.970.094 | 2,77% | Aktien |
| Invesco Ltd. | $329.847.848 | 20.771.275 | 1,92% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $320.873.980 | 20.206.170 | 1,87% | Aktien |
| AMERIPRISE FINANCIAL INC | $298.795.923 | 18.815.747 | 1,74% | Aktien |
| MORGAN STANLEY | $240.246.939 | 15.128.899 | 1,40% | Aktien |
| Bank of New York Mellon Corp | $226.894.280 | 14.288.053 | 1,32% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $215.449.390 | 13.567.342 | 1,26% | Aktien |
| GOLDMAN SACHS GROUP INC | $215.410.160 | 13.564.872 | 1,26% | Aktien |
| NORTHERN TRUST CORP | $159.414.412 | 10.038.691 | 0,93% | Aktien |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $156.853.255 | 9.877.409 | 0,91% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $132.934.942 | 8.371.218 | 0,77% | Aktien |
| Callodine Capital Management, LP | $127.051.783 | 8.000.742 | 0,74% | Aktien |
| DEUTSCHE BANK AG\ | $125.313.384 | 7.891.271 | 0,73% | Aktien |
| JPMORGAN CHASE & CO | $119.690.536 | 7.322.267 | 0,70% | Aktien |
| BANK OF AMERICA CORP /DE/ | $116.824.517 | 7.356.708 | 0,68% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $103.910.383 | 6.543.475 | 0,61% | Aktien |
| Qube Research & Technologies Ltd | $98.141.941 | 6.180.223 | 0,57% | Aktien |
| UBS Group AG | $96.745.659 | 6.092.296 | 0,56% | Aktien |
| Nuveen, LLC | $95.398.563 | 6.007.467 | 0,56% | Aktien |
| FRANKLIN RESOURCES INC | $89.856.011 | 5.658.439 | 0,52% | Aktien |
| JANE STREET GROUP, LLC | $88.440.659 | 5.569.311 | 0,52% | Aktien |
| Nantahala Capital Management, LLC | $79.400.000 | 5.000.000 | 0,46% | Kaufoption |
| Assenagon Asset Management S.A. | $79.225.415 | 4.989.006 | 0,46% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $74.556.065 | 4.694.966 | 0,43% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $73.760.258 | 4.644.851 | 0,43% | Aktien |
| Gotham Asset Management, LLC | $69.469.966 | 4.374.683 | 0,40% | Aktien |
| CITIGROUP INC | $69.243.850 | 4.360.444 | 0,40% | Aktien |
| Brandywine Global Investment Management, LLC | $67.528.501 | 5.423.976 | 0,39% | Aktien |
| Legal & General Group Plc | $64.625.994 | 4.069.647 | 0,38% | Aktien |
| NORGES BANK | $60.705.175 | 3.822.744 | 0,35% | Aktien |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $59.326.092 | 3.735.900 | 0,35% | Aktien |
| Man Group plc | $55.946.065 | 3.523.052 | 0,33% | Aktien |
| Russell Investments Group, Ltd. | $54.379.234 | 3.423.675 | 0,32% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $53.562.152 | 3.964.630 | 0,31% | Aktien |
| Amundi | $51.920.530 | 3.269.550 | 0,30% | Aktien |
| SEI INVESTMENTS CO | $50.267.814 | 3.165.469 | 0,29% | Aktien |
| ROYAL BANK OF CANADA | $49.792.000 | 3.135.460 | 0,29% | Aktien |
| RHUMBLINE ADVISERS | $45.614.656 | 2.872.464 | 0,27% | Aktien |
| DME Capital Management, LP | $44.042.703 | 2.773.470 | 0,26% | Aktien |
| Vanguard Global Advisers, LLC | $42.862.486 | 2.699.149 | 0,25% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $42.610.407 | 2.683.275 | 0,25% | Aktien |
Unternehmensinsider 32 Insider · 14 Führungskräfte · 20 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott Andrew Smith | Chief Executive Officer | 6. März 2026 A | 1.329.326 | 0 | 0 | $0 |
| Michael Goettler | Chief Executive Officer | 4. März 2023 M | 321.653 | 0 | 0 | $0 |
| Campbell Paul | Interim Chief Financial Officer, Chief Accounting Officer and Corporate Controller | 25. Juni 2026 S | 316.212 | 0 | 2 | $-1.093.257 |
| Theodora Mistras | Chief Financial Officer | 6. März 2026 A | 70.645 | 0 | 0 | $0 |
| Sanjeev Narula | Chief Financial Officer | 4. März 2023 M | 73.877 | 0 | 0 | $0 |
| Anthony Mauro | President, Developed Markets | 13. März 2024 S | 243.044 | 0 | 0 | $0 |
| Xiangyang (Sean) Ni | President, Greater China | 4. März 2024 A | 90.804 | 0 | 0 | $0 |
| Andrew Cuneo | President, JANZ (Japan, Australia and New Zealand) and Emerging Markets | 4. März 2024 A | 60.055 | 0 | 0 | $0 |
| Menassie Taddese | President, Emerging Markets | 27. Mai 2022 S | 0 | 0 | 0 | $0 |
| Andrew Enrietti | Chief Administrative and Transformation Officer | 15. August 2026 M | 234.444 | 0 | 0 | $0 |
| Corinne Le Goff | Chief Commercial Officer | 15. April 2026 M | 107.135 | 0 | 0 | $0 |
| Matthew Joseph Maletta | Chief Legal Officer | 6. März 2026 A | · | 0 | 0 | $0 |
| Brian Roman | Chief Legal Officer | 6. März 2025 A | 193.916 | 0 | 0 | $0 |
| Robert J Coury | Executive Chairman | 4. März 2023 M | 1.174.515 | 0 | 0 | $0 |
| Leo Frans Groothuis | Direktor | 30. September 2026 A | 63.437 | 0 | 0 | $0 |
| David S Simmons | Direktor | 30. September 2026 A | 23.344 | 2 | 0 | $5.202 |
| Richard A Mark | Direktor | 6. März 2026 A | 116.145 | 0 | 0 | $0 |
| Coelho Rogerio Vivaldi | Direktor | 6. März 2026 A | 46.526 | 0 | 0 | $0 |
| Michael Severino | Direktor | 6. März 2026 A | 26.031 | 0 | 0 | $0 |
| Dillon Joellen Lyons | Direktor | 6. März 2026 A | 102.526 | 0 | 0 | $0 |
| Mark W Parrish | Direktor | 6. März 2026 A | 165.230 | 0 | 0 | $0 |
| Elisha W Finney | Direktor | 6. März 2026 A | 62.667 | 0 | 0 | $0 |
| Frank A Damelio | Direktor | 6. März 2026 A | 26.031 | 0 | 0 | $0 |
| Don W Cornwell | Direktor | 6. März 2026 A | 112.044 | 0 | 0 | $0 |
| Melina E Higgins | Direktor | 6. März 2026 A | 146.048 | 0 | 0 | $0 |
| James M Kilts | Direktor | 6. März 2026 A | 161.257 | 0 | 0 | $0 |
| Rajiv Malik | Direktor | 6. März 2025 A | 1.068.262 | 0 | 0 | $0 |
| Harry Korman | Direktor | 6. März 2025 A | 113.937 | 0 | 0 | $0 |
| Mohr Pauline Van Der Meer | Direktor | 4. März 2023 M | 40.245 | 0 | 0 | $0 |
| Ian C Read | Direktor | 21. März 2022 M | 14.497 | 0 | 0 | $0 |
| Neil F Dimick | Direktor | 21. März 2022 M | 75.200 | 0 | 0 | $0 |
| Pfizer Inc. | 10%-Eigentümer | 16. November 2020 J | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 123 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| DUSA · Davis Fundamental ETF Trust | 5,37% | 3.886.641 NS | 31. Juli 2026 | N-PORT |
| ADPV · Series Portfolios Trust | 4,75% | 482.110 NS | 31. Juli 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 4,37% | 1.522.109 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 4,36% | 4.310.454 SH | 11. September 2026 | Täglich |
| PJP · Invesco Exchange-Traded Fund Trust | 3,40% | 1.069.356 SH | 1. Oktober 2026 | Täglich |
| CVSM · Elevation Series Trust | 2,66% | 143.081 NS | 31. Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 2,51% | 21.853 NS | 31. Juli 2026 | N-PORT |
| SPDV · ETF Series Solutions | 2,41% | 180.356 NS | 31. Juli 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2,03% | 8.379 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,76% | 865.399 SH | 1. Oktober 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 1,75% | 363.657 SH | 1. Oktober 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,50% | 896.631 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,33% | 81.239 SH | 1. Oktober 2026 | Täglich |
| RPV · Invesco Exchange-Traded Fund Trust | 1,30% | 1.201.310 SH | 1. Oktober 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,27% | 14.896 NS | 31. Juli 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 1,07% | 786.966 NS | 31. Juli 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1,04% | 587.982 NS | 31. Juli 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1,04% | 98.896 SH | 1. Oktober 2026 | Täglich |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,82% | 60.381 SH | 1. Oktober 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,78% | 146.604 NS | 31. Juli 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,75% | 49.232 SH | 1. Oktober 2026 | Täglich |
| MEDI · Harbor ETF Trust | 0,57% | 13.424 NS | 31. Juli 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,54% | 5.774.795 NS | 31. Juli 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,51% | 187.532 NS | 31. Juli 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,47% | 61.211 NS | 31. Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,43% | 113.494 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,43% | 493.425 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,39% | 16.955.526 SH | 19. August 2026 | Täglich |
| FBCV · FIDELITY COVINGTON TRUST | 0,39% | 39.217 NS | 31. Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,39% | 329.029 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,36% | 10.810.000 | 1. Oktober 2026 | Täglich |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,35% | 91.816 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,35% | 2.881.753 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,31% | 680.750 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,30% | 554.689 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,28% | 150.960 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,27% | 3.499.976 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,27% | 455.933 SH | 11. September 2026 | Täglich |
| SMMD · iShares Trust | 0,26% | 621.073 SH | 11. September 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,26% | 49.916 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,26% | 115.598 SH | 19. August 2026 | Täglich |
| IMCV · iShares Trust | 0,26% | 182.951 SH | 11. September 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 122.266 NS | 31. Juli 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,25% | 194.588 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 0,24% | 611.025 SH | 11. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,23% | 22.916 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,22% | 11.867.062 SH | 1. Oktober 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,22% | 26.707.011 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,19% | 1.735.168 SH | 11. September 2026 | Täglich |
| WSML · iShares Trust | 0,18% | 71.909 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,17% | 566.625 NS | 31. Juli 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,17% | 7.807.000 | 1. Oktober 2026 | Täglich |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 228.156 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 187.618 SH | 19. August 2026 | Täglich |
| LGDX · Tidal Trust III | 0,15% | 11.980 NS | 31. Juli 2026 | N-PORT |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,15% | 1.925.017 SH | 1. Oktober 2026 | Täglich |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,14% | 13.535 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,14% | 4.755.593 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,13% | 131.500 SH | 10. September 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,12% | 36.388 NS | 31. Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,11% | 622.740 SH | 1. Oktober 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,11% | 438.116 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,11% | 1.446 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 46.067 SH | 1. Oktober 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 55.744 SH | 1. Oktober 2026 | Täglich |
| DIVB · iShares Trust | 0,10% | 124.028 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,09% | 825.072 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,08% | 445.662 SH | 1. Oktober 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,08% | 4.647.551 SH | 19. August 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,07% | 272.031 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,07% | 21.814 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,06% | 1.747.680 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,06% | 1.934.171 SH | 11. September 2026 | Täglich |
| IUSV · iShares Trust | 0,06% | 1.017.393 SH | 11. September 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,06% | 267.075 SH | 19. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,06% | 110.597 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 44.089 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,05% | 2.579.107 SH | 11. September 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 701.858 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,04% | 358.281 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 52.351 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,04% | 35.636 SH | 1. Oktober 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,04% | 267.915 NS | 31. Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,04% | 720 SH | 9. September 2026 | Täglich |
| XRMI · Global X Funds | 0,04% | 1.009 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 1.200 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,03% | 13.227 SH | 11. September 2026 | Täglich |
| XYLD · Global X Funds | 0,03% | 58.008 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,03% | 58.253 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 6.830 SH | 1. Oktober 2026 | Täglich |
| XTR · Global X Funds | 0,03% | 85 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,03% | 37.920 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 362.786 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,03% | 62 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 30.255.873 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 36.993.850 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,03% | 192.700 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 97.596 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,03% | 262.709 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,03% | 4.573 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,03% | 4.394 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 14.678.463 SH | 11. September 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,03% | 28.053 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,03% | 21.777 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,03% | 814.020 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,03% | 49.059 SH | 11. September 2026 | Täglich |
| LRGF · iShares Trust | 0,03% | 59.492 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,03% | 1.524.327 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,03% | 315.944 SH | 11. September 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,03% | 8.100 NS | 31. Juli 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,02% | 863 SH | 1. Oktober 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,02% | 91.048 NS | 31. Juli 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 993.914 SH | 19. August 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 41.980 SH | 1. Oktober 2026 | Täglich |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
VTRS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 17 Analysten
KAUF
Median-Ziel
$20.00
+13,6%
4 23,5%
Starker Kauf
7 41,2%
Kauf
5 29,4%
Halten
1 5,9%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-09-30Mittelwert-Ziel $19.40 +10,2%
Jetzt
Aktueller Preis $17.60
Tief$13.00
Mittelwert$19.40
Hoch$25.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Was Investors Sollten Über Einen $24-Millionen-Rückzug Aus Einem Medizintechnik-Aktienwissen, Der 9 % Im Letzten Jahr Geringer Ist
Nasdaq · 6 Monate, 1 Woche vor
Viatris umreißt langfristige Finanzziele
Nasdaq · 6 Monate, 2 Wochen vor
Was sagen Analysten über Viatris Inc (VTRS) Aktie?
Yahoo Finance · 6 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026